Form 4: Catheter Precision Director Acquires Stock Options

James Joseph Caruso, a director of Catheter Precision, Inc., acquired stock options exercisable for 100,000 shares of common stock.

Summary

• James Joseph Caruso, a director of Catheter Precision, Inc. (VTAK), filed a Form 4.
• The form reports a transaction that occurred on January 29, 2025.
• Caruso acquired stock options for 100,000 shares of Catheter Precision's common stock with an exercise price of $0.42.
• The options expire on January 29, 2035.
• 33.33% of the options are exercisable on January 29, 2025, 33.33% on January 29, 2026, and 33.34% on January 29, 2027.
• Following the transaction, Caruso directly owns derivative securities for 100,000 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock option grants to a director. While insider ownership can be a positive signal, this is a relatively small grant and doesn't necessarily indicate a strong bullish or bearish outlook.

Positives

• The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

• The acquisition of stock options by a director could have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

Form 4, stock options, director, VTAK, Catheter Precision, insider trading